primary immunodeficiency Flashcards

1
Q

immunodeficiency diseases

A

Defects in one or more components of the immune system can lead to serious and often fatal disorders
-some associated with increased autoimmunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Primary immunodefiency

A

genetic, congenital disorders
immune system either missing or abnormal
-mainly caused by mutations
-predisposes to infections and tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Abnormality in Pri ID

A

components of innate system
stages of lymphocyte development
responses of mature lymphocytes to antigenic stimulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

congenital disorders

A

chronic granulomatous disease

Leukocyte adhesion defiency type 1 &2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

antibody deficiencies

A

agammaglobulinemias
X linked
Autosomal recessive
Hypogammaglobulinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Defects in T cell activation

A

proximal TCR signalling defects

wiskott- aldrich syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Neisseria

A

suspect defect in complement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

B cell defects

A

Encapsulated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Tuberculosis

A

Th1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Candida,
Infections with staphylococci, gram-negative bacteria, and fungi are associated with reduced number or function of phagocytes.

A

TH17

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

mycobacterium tuberculosis

A

causes lung infection in immunocompetent people.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

herpes simplex

A

Recurrent attacks of cold sores (herpes simplex) or shingles (herpes varicella zoster) may suggest mild immunodeficiency
-associated with stress and sick

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

T cell dysfunction

A

Herpesvirus-induced tumours, notably Kaposi sarcoma (human herpesvirus 8 [HHV8]), and non-Hodgkin lymphoma (Epstein-Barr virus [EBV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

causes of pri imm deficiency

A

mutations
polyporphisms
polygenic disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

mutation

A

permanent alteration in the DNA sequence that makes up a gene, such that the sequence differs from what is found in most people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

polymorphisms

A

different variations of same gene, different allele but still produce functional protein, but still can cause problems

17
Q

polygenic disorders

A

These are disorders caused by the combined action of more than one gene.
Polygenic disorders of the immune system are relatively common and affect mainly antibodies.

18
Q

severe combined immunodeficiency (group of diseases)

A

affect both T and B cells
die in the first few months of life unless treatment is given
autoso­mally inherited
Stem cell transplant can cure SCID but it has to be done quickly
screening

19
Q

types of SCID

A

defective pre TCR checkpoint
Di George syndrome
Fox N1 deficiency
X linked

20
Q

polymorphism

A
  • Human leukocyte antigen (HLA) alleles are polymorphic and affect the outcome of infections.
  • HLA alleles that are unable to bind viral peptides have a worse outcome.
  • Mannan-binding lectin (MBL) is a collagen-like protein that binds sugars in bacterial cell walls and activates the classic complement pathway. Polymorphisms in MBL and complement affect the risk for infections.
21
Q

polygenic disorders common variable immunodeficiency

A

requiring treatment and occurs in about 1 in 20,000 young people affecting men and women equally.
low levels of IgG
-recurrent respiratory tract infections.
-pneumococcus orHaemophilusspp. despite normal total IgG.
-autoimmunity common
-consanguinity

22
Q

Monogenic

A

T and B cells
autosomal recessive SCID
RAG mutations

23
Q

severe combined immunodeficiency clinical presdefective

A

defective T cells and B cells and therefore develop infections in the first few weeks of life.
Unusual or recurrent infection
Diarrhoea
Unusual rashes
History
Family history of neonatal death
Family history of consanguinity
Lymphocyte count
very low total lymphocyte count (less than 1 × 109/L [106/mL]).
Lymphocyte numbers should be measured by flow cytometry.

24
Q

antibody deficiency

A

Clinical presentation
Antibody deficiency presents later in life.
Babies are born with maternal immunoglobulin transferred across the placenta.
Some forms of antibody deficiency, such as CVID, do not present until adulthood.
Chronic or recurrent bacterial respiratory infection.
Antibody levels
IgG, IgA, and IgM should be measured.
With low levels of immunoglobulins, causes of secondary immunodeficiency should be excluded.
If total Igs are normal, specific antibodies against Haemophilus spp. and pneumococcus should be measured.
If these tests are all normal, it is important to check no problems are apparent with complement or neutrophil function.

25
Q

treatment of primary

A

mild-prophylactic antibiotics
more severe- Ig replacement therapy
Antibodies against a wide range of pathogens
Ig pooled
plasma screened for HIV and hepatitis B and C antibodies

26
Q

When definite treatment

A

when SCID confirmed
until definite
-avoding live vaccines
-Prophylaxis against opportunist infections such asPneumocystis jiroveci

27
Q

T cell deficiency stem cell transplatation

A

-required in SCID
most successful if it can be done within a few weeks of birth, before the infant has developed any infections.
If this is possible, SCT carries a 90% success rate and is curative.
When SCT is not an option, gene therapy may be attempted.

28
Q

gene therapy

A

recombinant technology to correct the genetic defect in the patient’s own stem cells, which can then reconstitute the immune system.
used in patients with SCID for whom no suitable stem cell donor was available.

criteria:

  1. The genetic mutation for each patient must be identified, and there must be evidence that correcting the mutation will improve his or her condition.
  2. The transfected gene must confer a proliferation or survival advantage.
  3. Gene therapy must not cause malignancy. (not near oncogenes)